Cargando…
Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study
Multiparametric assays for risk stratification are widely used in the management of both node negative and node positive hormone receptor positive invasive breast cancer. Recent data from multiple sources suggests that different tests may provide different risk estimates at the individual patient le...
Autores principales: | Bartlett, John M. S., Bayani, Jane, Kornaga, Elizabeth, Xu, Keying, Pond, Greg R., Piper, Tammy, Mallon, Elizabeth, Yao, Cindy Q., Boutros, Paul C., Hasenburg, Annette, Dunn, J. A., Markopoulos, Christos, Dirix, Luc, Seynaeve, Caroline, van de Velde, Cornelis J. H., Stein, Robert C., Rea, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266887/ https://www.ncbi.nlm.nih.gov/pubmed/34238931 http://dx.doi.org/10.1038/s41523-021-00297-7 |
Ejemplares similares
-
Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training
por: Bartlett, John M. S., et al.
Publicado: (2020) -
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
por: Bayani, Jane, et al.
Publicado: (2017) -
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
por: Bartlett, J M S, et al.
Publicado: (2013) -
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
por: Stephen, J, et al.
Publicado: (2014) -
Disagreeing in context
por: Marques, Teresa
Publicado: (2015)